SAGE-217

CAS : 1632051-40-1

Ref. 3D-HQC05140

Informations sur le produit

• Nom: SAGE-217
• Synonymes: 1-[(3α,5β)-3-Hydroxy-3-methyl-20-oxo-19-norpregnan-21-yl]-1H-pyrazole-4-carbonitrile, Zuranolone, 1H-Pyrazole-4-carbonitrile, 1-[(3α,5β)-3-hydroxy-3-methyl-20-oxo-19-norpregnan-21-yl]-, SAGE 217, 1-[2-[(3R,5R,8R,9R,10S,13S,14S,17S)-3-hydroxy-3,13-dimethyl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl]pyrazole-4-carbonitrile, 1H-Pyrazole-4-carbonitrile, 1-[(3α,5β)-3-hydroxy-3-methyl-20-oxo-19-norpregnan-21-yl]-, SGE 797

Description

SAGE-217 is a novel antidepressant drug that has been shown to be effective in the treatment of depression. The drug is orally administered and is rapidly absorbed, with peak plasma concentrations occurring within one hour. It binds to GABA receptors and blocks the binding of the neurotransmitter gamma-aminobutyric acid (GABA) to its receptor, which reduces brain activity and has an anti-anxiety effect. SAGE-217 may also have other effects on neurotransmitters, such as serotonin or dopamine, but this remains unclear.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 409.56 g/mol
• Formule: C₂₅H₃₅N₃O₂
• Degré de pureté: Min. 95%